Quick Answer
NANOVIRICIDES, INC. reported Research And Development Expense of $5.55 million for the year ending 2025.
- NANOVIRICIDES, INC. showed an increase of +2.1% in Research And Development Expense from 2024 to 2025.
- This data is from NANOVIRICIDES, INC.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2010: $1.11 million | Q1 2011: $1.65 million | Q3 2011: $691.7 thousand | Q4 2011: $1.01 million | Q1 2012: $1.58 million | Q3 2012: $1.21 million | Q4 2012: $710.2 thousand | Q1 2013: $1.36 million | Q3 2013: $1.17 million | Q4 2013: $1.13 million | Q1 2014: $625.7 thousand | Q3 2014: $811.1 thousand | Q4 2014: $916.7 thousand | Q1 2015: $546.5 thousand | Q3 2015: $1.28 million | Q4 2015: $1.15 million | Q1 2016: $1.07 million | Q3 2016: $1.45 million | Q4 2016: $1.26 million | Q1 2017: $1.56 million | Q3 2017: $1.45 million | Q4 2017: $1.64 million | Q1 2018: $1.29 million | Q3 2018: $1.41 million | Q4 2018: $1.66 million | Q1 2019: $1.31 million | Q3 2019: $1.48 million | Q4 2019: $1.01 million | Q1 2020: $1.13 million | Q3 2020: $1.57 million | Q4 2020: $1.49 million | Q1 2021: $1.46 million | Q3 2021: $2.10 million | Q4 2021: $1.26 million | Q1 2022: $1.26 million | Q3 2022: $1.11 million | Q4 2022: $1.17 million | Q1 2023: $1.20 million | Q3 2023: $1.47 million | Q4 2023: $1.57 million | Q1 2024: $1.21 million | Q3 2024: $1.93 million | Q4 2024: $1.16 million | Q1 2025: $1.28 million | Q3 2025: $993.1 thousand | Q4 2025: $1.12 million.
- Over the full 13 years of available data (2013 to 2025), NANOVIRICIDES, INC.'s Research And Development Expense has grown by 29.3%.
- Historical annual values: Fiscal year 2025: $5.55 million | Fiscal year 2024: $5.44 million | Fiscal year 2023: $6.39 million | Fiscal year 2022: $5.78 million | Fiscal year 2021: $6.11 million | Fiscal year 2020: $4.70 million | Fiscal year 2019: $5.92 million | Fiscal year 2018: $5.91 million | Fiscal year 2017: $6.57 million | Fiscal year 2016: $5.03 million | Fiscal year 2015: $3.66 million | Fiscal year 2014: $5.13 million | Fiscal year 2013: $4.29 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: